MedTrace Logo

Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression

NCT00234117 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-07-22

No results posted yet for this study

Summary

The purpose of this study is to determine if 20mg BID of Rabeprazole is effective in controlling GERD in patients with concomitant bronchial asthma and to assess improvement in asthma after reflux control.

Conditions

  • Bronchial Asthma
  • Gastroesophageal Reflux

Interventions

DRUG

Rabeprazole

Sponsors & Collaborators

  • PriCara, Unit of Ortho-McNeil, Inc.

    collaborator INDUSTRY

  • Ponce Gastroenterology Research

    lead OTHER

Principal Investigators

  • Alvaro Reymunde, MD · Ponce Gastroenterology Research

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31

Countries

  • Puerto Rico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00234117 on ClinicalTrials.gov